Plitidepsin Versus Control in Immunocompromised Adult Participants With Symptomatic COVID-19 Requiring Hospital Care (NEREIDA)
Clinical trial NCT05705167 · TERMINATED
Trial details
- NCT number
- NCT05705167
- Sponsor
- PharmaMar
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2024-03-19
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.